SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as news circulates about the departure of a key FDA official, which the community believes removes a significant hurdle and could accelerate the approval path for their Duchenne Muscular Dystrophy (DMD) therapy, Deramiocel; this development, combined with upcoming Phase 3 data presentations, is intensifying short squeeze and buyout speculation.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging as a key FDA official's departure and reports of a less invasive trial design for its Huntington's gene therapy ignite community hopes for accelerated approval, triggering a significant short squeeze after a week of regulatory setbacks.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending after completing an AI licensing partnership in Africa, which, combined with its low float and extremely high cost-to-borrow, is fueling intense short squeeze speculation among traders. The community is actively discussing strong buy-side pressure and the stock's resilience amidst a broader red market, with many holding for significant upside.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending amid widespread speculation and fervent debate among investors regarding its potential inclusion in the S&P 500. While many anticipate a significant price movement based on the decision, others express frustration over past dilutions and current market volatility, yet maintain confidence in the company's long-term growth and recent insider buying.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as escalating Middle East tensions and significant disruptions to the Strait of Hormuz drive oil prices to multi-year highs with historic weekly gains. Traders are fiercely debating whether this represents a sustainable "plumbing break" or an overextended "fear trade" ripe for a pullback, amidst discussions of potential US administration interventions to stabilize the market.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings (LITE) is trending amid its S&P 500 inclusion and a significant strategic investment from NVIDIA, solidifying its critical position in AI infrastructure expansion. The community is actively discussing whether its high valuation is justified by its role in supplying advanced optical components, particularly in light of industry perspectives on optical versus copper solutions for data center connectivity.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending with surging volume, fueled by intense short-covering and bullish community sentiment. Investors are optimistic about a significant re-rating, citing recent analyst upgrades, M&A buzz in the oncology sector, and anticipated data readouts for its promising TIL therapy platform.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as the anticipated departure of a key FDA official fuels community speculation for a significantly softened regulatory landscape for gene therapies, with many expecting SRPT to follow recent rallies in comparable biotechs ahead of upcoming pivotal DM1 and FSHD data readouts.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending amid significant insider debt-to-equity conversions improving its balance sheet and aggressive CEO compensation goals, fueled by recent defense contracts, U.S. Army qualification, and plans for a massive new factory. Investors are weighing the company's critical role in aerospace and defense against persistent concerns about high short interest and potential dilution.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility, drawing polarized community sentiment between dip-buyers confident in long-term AI demand and short-sellers citing geopolitical concerns and the ETF's repeated failure to break key resistance. The leveraged semiconductor fund is seeing rapid swings, driven by mixed reactions to sector earnings and broader market uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Red Violet (NASDAQ:RDVT) Stock Price Up 9% Following Earnings Beat

Red Violet (NASDAQ:RDVT) Trading 9% Higher Following Strong Earnings...

Red Violet Q4 Earnings Call Highlights

Red Violet (NASDAQ:RDVT) reported record fourth-quarter results and capped what executives called an exceptional year, citing broad-based demand across verticals, expanding enterprise adoption, and...

Red Violet (RDVT) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Red Violet (NASDAQ:RDVT) Posts Earnings Results, Beats Estimates By $0.06 EPS

Red Violet (NASDAQ:RDVT - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of...

Hillsdale Investment Management Inc. Lowers Holdings in Red Violet, Inc. $RDVT

Hillsdale Investment Management Inc. reduced its position in Red Violet, Inc. (NASDAQ:RDVT - Free Report) by 27.5% during the 3rd quarter, according to its most recent filing with the SEC. The firm...

Red Violet (NASDAQ:RDVT) Shares Down 13.4% - Should You Sell?

Red Violet (NASDAQ:RDVT) Stock Price Down 13.4% - Should You Sell...

Brown Capital Management LLC Has $19.73 Million Holdings in Red Violet, Inc. $RDVT

Brown Capital Management LLC trimmed its position in shares of Red Violet, Inc. (NASDAQ:RDVT - Free Report) by 19.6% during the 3rd quarter, according to its most recent Form 13F filing with the...

Red Violet, Inc. $RDVT Shares Purchased by Pembroke Management LTD

Pembroke Management LTD lifted its stake in Red Violet, Inc. (NASDAQ:RDVT - Free Report) by 9.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and...

Red Violet (NASDAQ:RDVT) Rating Increased to Strong-Buy at Zacks Research

Zacks Research raised shares of Red Violet from a "hold" rating to a "strong-buy" rating in a research report on Thursday...

Red Violet (NASDAQ:RDVT) Shares Down 6.3% - Should You Sell?

Red Violet (NASDAQ:RDVT) Shares Down 6.3% - Here's Why...

$RDVT Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.20 up 233.33% YoY
• Reported revenue of $23.39M up 19.56% YoY
• Red Violet Inc. expects to recognize $23.8M in future revenue from unsatisfied performance obligations for pricing contracts with terms over 12 months, including $12.7M in 2026.

Stocktwits

Red Violet Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.20 up 233.33% YoY
• Reported revenue of $23.39M up 19.56% YoY
• Red Violet Inc. expects to recognize $23.8M in future revenue from unsatisfied performance obligations for pricing contracts with terms over 12 months, including $12.7M in 2026.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$RDVT Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.20 up 233.33% YoY
• Reported revenue of $23.39M up 19.56% YoY
• Red Violet expects to recognize $23.8M in future revenue from unsatisfied performance obligations for pricing contracts with terms over 12 months. Additionally, Red Violet granted 832,690 RSUs to key executives, vesting upon achieving specified revenue and adjusted EBITDA margin targets by March 31, 2030.

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.20 up 233.33% YoY
• Reported revenue of $23.39M up 19.56% YoY
• Red Violet expects to recognize $23.8M in future revenue from unsatisfied performance obligations for pricing contracts with terms over 12 months. Additionally, Red Violet granted 832,690 RSUs to key executives, vesting upon achieving specified revenue and adjusted EBITDA margin targets by March 31, 2030.

Red Violet, Inc. engages in the provision of software and proprietary technology services. It specializes in data and analysis sector, which provides cloud-based, mission-critical information solutions to enterprises in a variety of industries. Its brands include IDI and Forewarn. The company was founded in August 2017 and is headquartered in Boca Raton, FL.

Current Price	$44.98
Prev Close	$46.28
Open	$45.05
Dividend Yield	0.00%
50-Day Moving Average	$47.46
Beta	1.08
Avg. Volume	126,724.23
PE Ratio	51.22

52-Week High	$64.14
52-Week Low	$32.23
Market Capitalization	$653.01M
EPS (Annual)	$0.9136
Price to Book	6.49
Revenue Per Employee	$361,008.00

RDVT
Red Violet Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RDVT News

RDVTRed Violet Inc